1st batch of Pfizer COVID-19 vaccine arrives in Japan Photo taken from a Kyodo News helicopter on Feb. 12, 2021, shows cargo being unloaded at Narita airport near Tokyo from an airplane that transported from Brussels the first batch to arrive in Japan of the coronavirus vaccine developed by U.S. pharmaceutical giant Pfizer Inc.

1st batch of Pfizer COVID-19 vaccine arrives in Japan Photo taken from a Kyodo News helicopter on Feb. 12, 2021, shows cargo being unloaded at Narita airport near Tokyo from an airplane that transported from Brussels the first batch to arrive in Japan of the coronavirus vaccine developed by U.S. pharmaceutical giant Pfizer Inc.

Choose your license

Rights Managed:

One-time editorial use in an online article, social media channels, internal presentation, website, newsletter, or blog.

One-time editorial use in a book, newspaper or magazine (excluding cover page), external presentation. Limited to 5,000 circulation. This includes the rights available in the Standard license.

Media Info

Credit: Kyodo News

Media ID:

Recording Date: Feb 12, 2021

Media Size: 2,208×1,338 Pixels

1st batch of Pfizer COVID-19 vaccine arrives in Japan Photo taken from a Kyodo News helicopter on Feb. 12, 2021, shows cargo being unloaded at Narita airport near Tokyo from an airplane that transported from Brussels the first batch to arrive in Japan of the coronavirus vaccine developed by U.S. pharmaceutical giant Pfizer Inc.

Restrictions: This image can only be published in Austria, Belgium, Bosnia and Herzegovina, Bulgaria, Czech Republic, Denmark, Estonia, Finland, France, Georgia, Germany, Greece, Hungary, Iceland, Ireland, Italy, Latvia, Lithuania, Liechtenstein, Macedonia, Norway, Portugal, Poland, Slovakia, Switzerland, Serbia, Slovenia, Spain, Turkey, United Kingdom and United Arab Emirates.

Release Info: Do I need a release?

Captions may have been translated or enriched by an AI system.
For more information about AI-assisted captions, see AI-assisted captions.

Need a custom license?

If your intended use isn't covered by the available options (such as non-editorial purposes or specific distribution needs), contact us. Our team will be happy to provide a tailored offer based on your requirements.